• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(TSX:SVA)

0.1150 UNCHANGED
Delayed Quote Updated: 1:08 PM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,500
Open 0.1150
Bid (Size) 0.1150 (115)
Ask (Size) 0.1200 (340)
Prev. Close 0.1150
Today's Range 0.1100 - 0.1150
52wk Range 0.0850 - 0.2000
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
SINOVAC Reports Unaudited First Half of 2026 Financial Results
August 17, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
July 15, 2026
From Sinovac Biotech Ltd.
Via Business Wire

Performance

52-Week Range 42.5% below 52-week high
0.1150
0.0952W Low 0.2052W High
1 Week 4.2% below 1-week high
0.101W Low 0.121W High

(SVA) traded between $0.09 and $0.20 over the past 52 weeks and last traded at $0.12, 42.5% below its 52-week high. Over the past week it ranged between $0.10 and $0.12.

Past 12 Months
+4.5%
+9.5%
+4.5%
-36.1%
-8.0%
-34.3%
1W +$0.01
1M +$0.01
3M +$0.01
6M -$0.06
YTD -$0.01
1Y -$0.06

SVA was -34.3% over the past year, -36.1% over six months, -8.0% year to date, +4.5% in the last week.

12 Months vs Market
SVA
-34.3%
DIA
+12.3%
SPY
+14.7%
QQQ
+17.6%
IWM
+11.2%

Over the past 12 months SVA returned -34.3% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.7%, QQQ (Nasdaq 100) +17.6% and IWM (Russell 2000) +11.2%.

Volume & Liquidity 0.07× 3-mo avg
Today 13,500 3-mo avg 206.2K
1W
76.3K
1M
246.0K
3M
206.2K
6M
169.6K
YTD
147.3K
1Y
142.6K

SVA most recently traded 13,500 shares against a 3-month average daily volume of 206.2K.

More News

Read More
News headline image
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements
June 15, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F
June 05, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
May 29, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
May 21, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Reports Unaudited First Half of 2025 Financial Results
May 08, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024
April 30, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗
March 15, 2026
Via The Motley Fool
News headline image
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗
March 15, 2026
Via The Motley Fool
News headline image
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
February 20, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
January 22, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
January 04, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
January 04, 2026
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
December 17, 2025
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
December 16, 2025
From USA News Group
Via GlobeNewswire
News headline image
Newly Elected Directors of Sinovac Hold the First Board Meeting
July 10, 2025
From Sinovac Biotech Ltd.
Via Business Wire
News headline image
Sinovac Shareholders Vote to Remove Current Directors and Elect SAIF Partners Nominees to Board at Special Meeting
July 09, 2025
From SAIF Partners IV L.P.
Via Business Wire
News headline image
Appeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder Vote
July 09, 2025
From Vivo Capital
Via Business Wire
News headline image
CORRECTING and REPLACING SAIF Partners: Now is Your Last Chance to Vote for Board Change at Sinovac
July 02, 2025
From SAIF Partners IV L.P.
Via Business Wire
News headline image
United States District Court of Massachusetts Bars Activist 1Globe Capital and Jiaqiang Li From Making Further Materially Misleading Statements Regarding Sinovac
July 02, 2025
From Vivo Capital
Via Business Wire
News headline image
SAIF Partners Sends Letter to Sinovac Shareholders
July 01, 2025
From SAIF Partners IV L.P.
Via Business Wire
News headline image
SAIF Partners Sends Open Letter to Sinovac Shareholders Outlining Current Board’s Failure to Act in the Interests of Shareholders
June 24, 2025
From SAIF Partners IV L.P.,
Via Business Wire
News headline image
Sinovac Clears Legal Hurdle In Control Battle, Moves Forward With $55 Dividend ↗
June 22, 2025
Via Stocktwits
News headline image
Prime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special Meeting
June 21, 2025
From Prime Success L.P.
Via Business Wire

Frequently Asked Questions

Is SVA publicly traded?
Yes, SVA is publicly traded.
What exchange does SVA trade on?
SVA trades on the Toronto Stock Exchange
What is the ticker symbol for SVA?
The ticker symbol for SVA is SVA on the Toronto Stock Exchange
What is the current price of SVA?
The current price of SVA is 0.1150
When was SVA last traded?
The last trade of SVA was at 10/20/26 01:08 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap